Clinical Trial Update: A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of disitamab vedotin in combination with other anticancer drugs for solid tumors is currently recruiting, including various breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)

Snippet

Sponsor: Seagen, a wholly owned subsidiary of Pfizer | Conditions: Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: RECRUITING